The presentation and progression of AS can vary greatly among individuals. Some may experience milder symptoms and slower disease progression, while others may face more aggressive disease activity and rapid joint damage. Understanding these variations and the heterogeneity of AS is crucial for tailoring treatment plans and providing personalized care to meet the unique needs of each individual.